PLENARY SPEAKERS

SESSION SPEAKERS (listed in alphabetical order by surname)

• Professor Ben Adler, Director, ARC Centre of Excellence in Structural and Functional Microbial Genomics
• Mr Anthony Arundel, Policy Analyst, Organisation for Economic Co-operation and Development (OECD)
• Professor Tony Bacic, University of Melbourne
• Dr Rashmi Barbaiya, CEO and Managing Director, Advinus Therapeutics Ptv Ltd, India
• Dr Russell Basser, Global Director of Clinical Development, CSL Limited
• Mr Cameron Begley, Business Development Manager, CSIRO Entomology
• Dr Glenn Begley, Vice President and Global Head of Hematology and Oncology Research, Amgen Inc, USA
• Kian Teik Beh, Deputy Director Biomedical Sciences, Singapore Economic Development Board, Singapore
• Dr Graeme Blackman, Chairman, Institute of Drug Technology Australia Ltd
• David Blake, Co-founder and Co-editor, Bioshares
• Dr Andrew Blattman, Principal, Spruson & Ferguson
• Dr Brian Bloomquist, Manager Global External Research and Development, Eli Lilly and Company, USA
• Dr Mark Bonnar, Investment Manager, Cleantech Ventures
• Professor Richard Boyd, Chief Scientific Officer, Norwood Immunology
• Dr Arthur Brandwood, Principal, Brandwood Biomedical Pty Ltd
• Garold Briet, Executive Director, University of Manitoba Technology Transfer Office, Manitoba, Canada 
• Professor Glenn Browning, Professor in Veterinary Biology, University of Melbourne
• Dr Stevens Brumbley, Project Leader, Australian Institute for Bioengineering and Nanotechnology
• Al Bryant, General Manager, Boeing Phantom Works 
• Professor Anothony Burkitt, Chair of Bio-signals and Bio-systems, Department of Electronic Engineering, The University of Melbourne
• Dr Christopher Cabell, Chief Medical and Scientific Officer, Quintiles Transnational Corporation, USA
• Dr James Campbell, Chief Operating Officer, ChemGenex Pharmaceuticals Limited
• Dr Simon Carroll, Deputy Chairman, AusBiotech Ltd 
• Dr Wing Kai Chan, Director, National Clinical Trial and Research Center and Deputy Director, Medical Research Department, National Taiwan University Hospital, Taiwan
• John Clerici, Partner, McKenna Long & Aldridge LLP, USA
• Shaun Colley, Consultant Cleantech, eG Capital
• Dr Karl Cornelius, Director, Strategic Marketing, Hospira
• Trevor Cornell, Chief Operating Officer, Industrial Technology Centre (ITC), Manitoba, Canada 
• Dr Andrew Cuthbertson, R&D Director and Chief Scientific Officer, CSL Limited
• Professor James Dale AO, Director, Centre for Tropical Crops and Biocommodities, Queensland University of Technology
• Dr Barbara Dalton, Vice President Venture Capital, Pfizer Inc, USA
• Clive Davenport, Chief Executive Officer, Small Technologies Cluster
• Simon De Young, Partner, Baker & McKenzie
• Claire Driscoll, Director, Technology Transfer Office, National Human Genome Research Institute, US National Institute of Health, USA
• Ram Deshpande, Senior Manager, Intellectual Property, Evalueserve Business Consulting (Shanghai) Co., China
• Sergio Duchini, Partner, National R&D & Tax Incentives Leader, Tax Services, Deloitte Touche Tohmatsu
• Dr Jackie Fairley, Chief Executive Officer, Starpharma Pty Ltd 
• Dr Leigh Farrell, Vice President Business Development, Biota Holdings Limited
• Dr Michael Fenech, Theme Leader: Nutrigenomics and Nutrigenetics - Personalised Nutrition for Health and Minds, CSIRO Human Nutrition, Food Science Australia
• Joyce Frey-Vasconcells, Executive Director, Pharmanet Consulting, USA
• Dr David Garman, Executive Director, Environmental Biotechnology CRC
• Michael Gilbert, General Manager and Company Secretary, Australian Centre for Plant Functional Genomics Pty Ltd
• Dr James Gilkerson, Senior Lecturer in Veterinary Microbiology, University of Melbourne
• Dr Dianne Glenn, Principal, Corelli Consulting 
• Dr Steve Gourlay, Partner, GBS Ventures Partners 
• Dr Daniel Grant, Head of Strategic Alliances, Pfizer Australia 
• Dr Allan Green, Program Leader of the Metabolic Engineering of New Plant Products, CSIRO Plant Industry
• Bill Guo, Chief Executive Officer, Venturepharm Group, China
• Dr Lisa Haile, Attorney / Partner, DLA Piper LLP, USA
• Peter Hobman, General Manager, MG Nutritionals
• Dr Seung Ho Han, Director, Gangwon Regional Innovation Agency, South Korea
• Richard Haiduck, Chief Business Advisor, Implicit Bioscience Limited / Cytopia 
• Denis Hanley AM, Principal, PFM Cornerstone Limited
• Dr Douglas Hawkins, Program Manager, Green Chemistry, Rohm and Haas Company, USA
• Professor Takao Hayakawa, Senior Advisor, Pharmaceuticals and Medical Devices Agency, Japan 
• Timothy Herpin, Director, Strategic Transactions Group, Bristol-Myers Squibb
• Dr John Holaday, Managing Director and CEO, QRxPharma Ltd
• Dr Ross J Horsburgh, Vice President Global Clinical Development Asia Pacific, Kendle International Inc, Singapore 
• Matthew Hoskin, Global Marketing Director, Leica Microsystems
• Dr Leonie Hunt, Director of the Office of Prescription Medications, Therapeutic Goods Administration  
• Leo Hyde, Research and Development Director Australia/New Zealand and ASEAN, Dupont Australia
• Dr David Irving, Manager (Acting) National Research and Business Development, Australian Red Cross Blood Service 
• Dr Dianne Jackson-Matthews, Director, ERA Consulting Australia
• Dr Peter Jones, Director, Richardson Center for Functional Foods, Manitoba, Canada
• Graeme Kaufman, Chief Investment Officer, Strategic Life Sciences
• Dr Kishan Khemani, Chief Technology Officer, Plantic
• Dr Malathi Lakshmikumaran, Lakshmikumaran & Sridharan Advocates, India 
• Ed Lehrburger, President, PureVision Technology Inc., USA 
• Brandon Lewis, Managing Director, The Trout Group LLC, USA 
• Dr Calvin London, CEO / Managing Director, Stirling Products Limited
• Lynda Lowry, General Manager & COO, Food Development Centre - a special operating agency of Manitoba Agricultural, Rural and Food Initiatives, Manitoba, Canada 
• Dr Michael Lusis, Business Director, Corporate Finance, Wilson HTM Investment Group
• Katsumi Maruyama, Director, V2V Pty Ltd
• Andrew Mitchell, Strategic Adviser, Pharmaceutical Evaluation Branch, Department of Health and Ageing, Australian Government 
• Professor Els Meeusen, Department of Physiology, Monash University
• Dr Lisa McIntyre, Director, L.E.K Consulting 
• Sean McKay, Executive Director, Composites Innovation Centre, Manitoba, Canada 
• Graeme McRae, Chairman, President and CEO, Bioniche Life Sciences, Canada
• Dr Stephen Meller, Head of Global Biosciences Business Development, The Procter & Gamble Company, USA
• Mark Morrison, Chief Executive Officer, Universal Biosensors
• Dr Dean Moss, General Manager, Life Sciences Technology, UniQuest
• Jim Murray, Chief Executive Officer, AT-Bio Pty Ltd 
• Professor Stephen Myers, Head NatMed Research Unit, Southern Cross University
• Professor Lars Nielsen, Professor and Chair of Biological Engineering, Australian Institute for Bioengineering and Nanotechnology 
• Mr Timothy Oldham, President Asia Pacific, Hospira Inc 
• Sue O'Malley, Principal Consultant and Founder, Medical Intelligence
• Edmund O'Shaunghnessy, Senior Consultant, Invetech Manufacturing Group, Invetech Pty Ltd 
• Dr Eli Opper, Chief Scientist, Ministry of Industry, Trade and Labor, Israel 
• Toby Patten, Senior Associate, Baker & McKenzie
• Dr Scott Patterson, Executive Director, Medical Sciences, Amgen Inc, USA
• Damien Perriman, Business Leader Biosciences, The Dow Chemical Company, USA
• Dr Susan Pond AM, Managing Director, Johnson & Johnson Research Pty Limited & Chairman, AusBiotech Ltd
• Ping Poulsen, President & CEO, Safis Solutions LLC, Indiana, USA
• Michael Quinn, Managing Partner, Innovation Capital
• Dr Deborah Rathjen, CEO and Managing Director, Bionomics Ltd 
• Dr Craig Rayner, Global Due Diligence Director, Roche, Switzerland
• Garry Redlich, Chief Executive Officer, Implicit Bioscience Ltd
• Dr Sang-Ki Rhee, Senior Research Fellow, Korea Institute of Bioscience and Biotechnology, South Korea 
• Professor Julian Rood, Department of Microbiology, Monash University
• Dr Manuel Sainz, Group Leader, Sugarcane Research, Syngenta Centre for Sugarcane Biofuels Development, Centre for Tropical Crops and Biocommodities, Queensland University of Technology
• Professor Robert Shepherd, Director, The Bionic Ear Institute
• Associate Professor Peter Seligman, Senior Biomedical Engineer, Cochlear Ltd 
• Dr Evan Siegel, President and CEO, Ground Zero Pharmaceuticals, USA
• Dr Annie Solterbeck, Director, Statistical Revelations Pty Ltd 
• Professor Stan Skafidas, National ICT Australia Limited
• Dr Merilyn Sleigh, Principal, InAvanti Life Sciences Consulting
• Dr Gillian Sparkes, Chief Executive Officer, Australian Sustainable Industry Research Centre
• Michael Spooner, Chairman, Hunter Immunology Limited 
• Trevor Stuthridge, Group Manager Sustainable Design, SCION, New Zealand
• Associate Professor Gregg Suaning, Centre for Implantable Bionics, University of NSW
• Shrikumar Suryanarayan, Director General, Association of Biotechnology Led Enterprises (ABLE), India
• Dr Colin Sutton, Director, Mission Pty Limited   
• Professor Linda Tapsell, Director, Smart Foods Centre, University of Wollongong  
• Peter Taylor, Chief Executive Officer, V-Patch Medical Systems
• Rob Thomas, Chief Sustainable Systems, South Australian Research Development Institute  
• Dr Richard Treagus, Chief Executive Officer, Acrux Ltd
• Professor Mike Vitale, Director, Monash Asia-Pacific Centre for Science and Wealth Creation
• Dr Graeme Wald, Head of Life Sciences Research, Wilson HTM Investment Group
• Dr Dominic Wall, Operations Director, Centre for Blood Therapies, Peter MacCallum Cancer Centre
• Dr Greg Wiederrecht, Vice President and Head of External Scientific Affairs, Merck & Co. Inc., USA
• Dr Nina Wilkins, Director, Business Development, Acrux Ltd
• Simon Yarrow, Chief Executive Officer, EnCoate, New Zealand
  • Ben Yerbury, Associate Director Business Development & Strategic Planning, Baxter Healthcare Pty Limited